Hansen & Associates Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Hansen & Associates Financial Group's LLY Position: Q2 2026 in Review
Hansen & Associates Financial Group reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $160K and leaving 945 shares worth $1.13M. The position accounts for 0.65% of the portfolio, ranked #33.
Hansen & Associates Financial Group first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.48M in Q4 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hansen & Associates Financial Group held 945 shares of Eli Lilly worth $1.13M as of Q2 2026.
- Hansen & Associates Financial Group sold 157 Eli Lilly shares in Q2 2026, an estimated $160K.
- Eli Lilly made up 0.65% of Hansen & Associates Financial Group's portfolio in Q2 2026, its #33 holding.
- Hansen & Associates Financial Group first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
- Hansen & Associates Financial Group's Eli Lilly position peaked at $1.48M in Q4 2025.
- 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hansen & Associates Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.